IMMUTEP Ltd

IMMP chart

IMMUTEP Ltd news

• Immutep Reports IMP761 T-Cell Inhibition Data at ACR 2026

  TipRanks · Nov 10, 6:40 AM EST

• Immutep Ltd (ASX:IMM) Shares Slide: What's Behind the Move?

  Kalkine · Nov 10, 3:04 AM EST

• Immutep jumps 24% on positive trial data

  grafa.com · Nov 9, 5:37 PM EST

• Immutep Limited (IMMP) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Nov 9, 2:37 PM EST

• Immutep Limited (ASX:IMM) Shares Jump 26% as Cash Runway Stretches Into 2028 and IMP761 Heads to ACR

  Kalkine · Nov 9, 12:18 AM EST

• Immutep IMP761 Phase I Data Shows Statistically Significant T-Cell Inhibition at ACR Convergence 2026

  Kalkine · Nov 8, 11:33 PM EST

• Immutep Limited (IMMP) stock price, news, quote and history

  Yahoo Finance Australia · Nov 8, 11:21 PM EST

• Immutep Reports Exposure-Dependent Inhibition of T-Cell-Driven Responses in IMP761 Phase I Study

  Small Caps · Nov 8, 9:53 PM EST

• Immutep (IMMP) Reports Positive Phase I Data for IMP761 at ACR Convergence 2026

  GuruFocus · Nov 8, 8:51 PM EST

• Daily Special: Immutep, DUG Technology, PhosCo, Native Mineral Resources, Elsight, ClearVue Technologies

  Sharecafe · Nov 8, 8:42 PM EST

• Immutep's IMP761 shows significant immune suppr...

  Pluang · Nov 8, 5:57 PM EST

• IMP761 Late-Breaking Abstract at ACR Convergence 2026

  GlobeNewswire · Nov 8, 5:34 PM EST

IMMUTEP Ltd key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-11-10
• 6-K6-K2026-11-02
• 6-K6-K2026-10-29
• 20-F20-F2026-10-23
• 6-K6-K2026-10-14
• 6-K6-K2026-09-22
• 6-K6-K2026-09-11
• 6-K6-K2026-09-02
• 6-K6-K2026-08-03
• 6-K6-K2026-07-14
• 6-K6-K2026-06-05
• 6-K6-K2026-05-01

About IMMUTEP Ltd

Ticker

IMMP (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Sydney,, Australia

Incorporated in

Australia

Fiscal year end

June 30

SEC CIK

1506184

Former names

Prima BioMed Ltd

Frequently asked questions